bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells.

Delia, D; Aiello, A; Soligo, D; Fontanella, E; Melani, C; Pezzella, F; Pierotti, MA; Della Porta, G

Abstract:

The present study provides immunobiochemical and molecular data on the differentiation-linked expression of the bcl-2 proto-oncogene in normal and neoplastic myeloid cells. Using a recently developed monoclonal antibody (MoAb) to the bcl-2 molecule, staining of normal bone marrow myeloblasts, promyelocytes, and myelocytes, but neither monocytes nor most polymorphonuclear cells, was demonstrated. By two-color flow cytometric analysis, bcl-2 was evidenced in CD33+ and CD33+/CD34+ myeloid cells ...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Delia, D., Aiello, A., Soligo, D., Fontanella, E., Melani, C., Pezzella, F., Pierotti, M. A., & Della Porta, G. (1992). bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood, 79(5), 1291–1298.

MLA Style

Delia, D., et al. “Bcl-2 Proto-Oncogene Expression in Normal and Neoplastic Human Myeloid Cells.” Blood, vol. 79, no. 5, 1992, pp. 1291–98.

Chicago Style

Delia, D, A Aiello, D Soligo, E Fontanella, C Melani, F Pezzella, MA Pierotti, and G Della Porta. 1992. “Bcl-2 Proto-Oncogene Expression in Normal and Neoplastic Human Myeloid Cells.” Blood 79 (5): 1291–98.
Tweet
Print